Set Measure ID | Measure Short Name |
---|---|
STK-1 | Venous Thromboembolism (VTE Prophylaxis) |
STK-10 | Assessed for Rehabilitation |
STK-2 | Discharged on Antithrombotic Therapy |
STK-3 | Anticoagulation Therapy for Atrial Fibrillation/Flutter |
STK-4 | Thrombolytic Therapy |
STK-5 | Antithrombotic Therapy By End of Hospital Day Two |
STK-6 | Discharged on Statin Medication |
STK-8 | Stroke Education |
Element Name | Collected For |
---|---|
Admission Date | All Records, |
Birthdate | All Records, |
Discharge Date | All Records, Not collected for HBIPS-2 and HBIPS-3 |
Hispanic Ethnicity | All Records, |
ICD-10-CM Other Diagnosis Codes | All Records, Optional for HBIPS-2, HBIPS-3 |
ICD-10-CM Principal Diagnosis Code | All Records, Optional for HBIPS-2, HBIPS-3 |
ICD-10-PCS Other Procedure Codes | All Records, Optional for All HBIPS Records |
ICD-10-PCS Other Procedure Dates | All Records, Optional for All HBIPS Records |
ICD-10-PCS Principal Procedure Code | All Records, Optional for All HBIPS Records |
ICD-10-PCS Principal Procedure Date | All Records, Optional for All HBIPS Records |
Measure Category Assignment | All Records, Calculation, Used in calculation of the Joint Commission's aggregate data. |
Payment Source | All Records, Optional for HBIPS-2 and HBIPS-3 |
Race | All Records, |
Sex | All Records, |
Element Name | Collected For |
---|---|
Measure Category Assignment | All Records, Calculation |
Hospitals that choose to sample have the option of sampling quarterly or sampling monthly. A hospital may choose to use a larger sample size than is required.
Hospitals whose Initial Patient Population size is less than the minimum number of cases per quarter/month for the sub-population cannot sample that sub-population. Regardless of the option used, hospital samples must be monitored to ensure that sampling procedures consistently produce statistically valid and useful data. Due to exclusions, hospitals selecting sample cases MUST submit AT LEAST the minimum required sample size.
The following sample size tables for each option automatically build in the number of cases needed to obtain the required sample sizes. For information concerning how to perform sampling, refer to the Population and Sampling Specifications section in this manual.
A modified sampling procedure is required for hospitals performing quarterly sampling for STK. The measure set contains two independent sub-populations: Ischemic STK patients and Hemorrhagic STK patients. The two sub-populations must be sampled independently from each other.
1.Hospitals selecting sample cases for the Ischemic sub-population must ensure that its Initial Patient Population and sample size for the Ischemic sub-population meets the following conditions: Average Quarterly Initial Patient Population “N” |
Minimum Required Sample Size “n” |
---|---|
≥ 900 | 180 |
226-899 | 20% of the Initial Patient Population |
45-225 | 45 |
6 - 44 | No sampling; 100% of the Initial Patient Population is required |
0 - 5 | Patient level data must be processed in order to submit your aggregate data. Submission of aggregate data is still required. The required quarterly sample size would be 100% of the patient population or 5 cases for the quarter |
Average Quarterly Initial Patient Population “N” |
Minimum Required Sample Size “n” |
---|---|
≥ 900 | 180 |
226-899 | 20% of the Initial Patient Population |
45-225 | 45 |
6 - 44 | No sampling; 100% of the Initial Patient Population is required |
0 - 5 | Patient level data must be processed in order to submit your aggregate data. Submission of aggregate data is still required. The required quarterly sample size would be 100% of the patient population or 5 cases for the quarter |
Average Monthly Initial Patient Population “N” |
Minimum Required Sample Size “n” |
---|---|
≥ 300 | 60 |
76-299 | 20% of the Initial Patient Population |
15-75 | 15 |
< 15 | No sampling; 100% Initial Patient Population required |
Average Monthly Initial Patient Population “N” |
Minimum Required Sample Size “n” |
---|---|
≥ 300 | 60 |
76-299 | 20% of the Initial Patient Population |
15-75 | 15 |
< 15 | No sampling; 100% Initial Patient Population required |
CPT® only copyright 2022 American Medical Association. All rights reserved. CPT® is a registered trademark of the American Medical Association.
You, your employees and agents are authorized to use CPT® only as contained in The Joint Commission performance measures solely for your own personal use in directly participating in healthcare programs administered by The Joint Commission. You acknowledge that the American Medical Association (“AMA”) holds all copyright, trademark and other rights in CPT®.
Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT® for resale and/or license, transferring copies of CPT® to any party not bound by this Agreement, creating any modified or derivative work of CPT®, or making any commercial use of CPT®. License to use CPT® for any use not authorized herein must be obtained through the American Medical Association, Intellectual Property Services, AMA Plaza, 330 North Wabash Avenue, Suite 39300, Chicago, Illinois 60611-5885. Applications are available at the American Medical Association Web site, www.ama- assn.org/go/cpt.
U.S. Government Rights This product includes CPT® which is commercial technical data, which was developed exclusively at private expense by the American Medical Association, 330 North Wabash Avenue, Chicago, Illinois 60611. The American Medical Association does not agree to license CPT® to the Federal Government based on the license in FAR 52.227-14 (Data Rights - General) and DFARS 252.227-7015 (Technical Data - Commercial Items) or any other license provision. The American Medical Association reserves all rights to approve any license with any Federal agency.
Disclaimer of Warranties and Liabilities. CPT® is provided “as is” without warranty of any kind, either expressed or implied, including but not limited to the implied warranties of merchantability and fitness for a particular purpose. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT®, and the (AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this product is with The Joint Commission, and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this product.
This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.
Should the foregoing terms and conditions be acceptable to you, please indicate your agreement and acceptance by clicking below on the button labeled “accept”.